Sentinel 3.0 Data Partners IDIQ

The goal of the next Sentinel 3.0 System contract is to continue meeting or exceeding the legislative requirements, promote program efficiency, support the anticipated needs of each of the distinctive underlying Sentinel 3.0 components (e.g., Active Postmarket Risk Identification and Analysis (ARIA) system), and ensure sufficient flexibility to address. Although not within the scope of this IDIQ, FDA envisions that other government organizations (e.g., Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH)) may also have an interest in leveraging the Sentinel 3.0 System (i.e., Data Platform and the data provided by the participating data contractors) to support the advancement of public health.

Estimated value

>= $50M and < $100M

Est. solicitation date

Sep 1, 2026

Anticipated award

Mar 1, 2027

• NAICS518210
• PSC518210